Lung cancer is the leading cause of cancer-related deaths. Over the past 10 years,
significant advances in treatment modalities, including immune checkpoint inhibitor (ICI) …

The microbiome of the lungs, although until recently neglected, is now emerging as a
potential contributor to chronic lung diseases, including cancer. Preclinical evidence …

Over the past couple of years, human microbiome has received increasing attention as a
regulator and predictor of response to the therapies of various diseases. It is speculated that …

The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …

Simple Summary In the past few years, the microbiota has emerged as a major player in
cancer management. The efficacy of chemotherapy or immunotherapy may be influenced by …

The gut microbiome is a collection of diverse bacteria that normally reside within the
gastrointestinal tract. In recent years, the relationship between the gut microbiome, and …

Simple Summary Lung cancer is the major cause of cancer related deaths in the world. New
therapies have improved outcomes. Unfortunately, overall 5 year survival is~ 20 …

Lung cancer is still the leading cause of cancer death worldwide. Despite the major
diagnostic and therapeutic innovations, the effect on mortality has been modest and the …

The gastrointestinal microbiome has been shown to play a key role in determining the
responses to cancer immunotherapy, including immune checkpoint inhibitor (ICI) therapy …

The microbiome is extremely important for human health; more recently its role in the context
of cancer became clear. Microbial effects range from enhancing cancer immunity and cancer …